Saamya Biotech (India) submits un-audited financial results

23 Feb 2019 Evaluate

Saamya Biotech (India) has informed about submission of Un-audited financial results for the Second quarter ending 30th September 2018 along with Limited Review Report. The Board Meeting Commenced at 4 PM and concluded at 5:15 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1540.30
Dr. Reddys Lab 5872.65
Cipla 1481.55
Zydus Lifesciences 1076.45
Lupin 1712.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.